101-PGC-005

· 101 Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 101-PGC-005, covering 2023-05-30 to 2023-05-30. Get the full timeline:

Most recent: Clinical Trial Update: 101-PGC-005 for the Treatment of COVID-19 [Phase 2]